Rocket Lab’s $57 Share Price is a Highly Attractive Entry Point For Forward-Looking Bulls

Published November 17, 2026, 7:15am ET · 3 min read

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

A white Rocket Lab Electron rocket, with a black nose cone, stands vertically on a concrete launchpad next to a tall, open-frame metal gantry structure. The launch complex is situated on a sandy coastline, with the calm ocean visible in the background under a light blue sky. Concrete pathways and metal railings lead to and from the launchpad, including an entrance to an underground facility. Various utility structures and pipes are visible on the right side of the complex.
A Rocket Lab Electron rocket awaits launch on a coastal pad, symbolizing the company's ambitious growth and strategic positioning as a full-stack space leader. © 24/7 Wall St.

Rocket Lab (NASDAQ:RKLB | RKLB Price Prediction) has turned into a full-stack space company. It flies Electron and HASTE, makes Flatellite spacecraft and has already took over Mynaric and Motiv. A deal for Iridium Communications (NASDAQ:IRDM) is still pending. CEO Peter Beck put it this way: “Our end-to-end space strategy is delivering exactly as designed.”[1] The stock has moved the other way. Shares are down 17.76% year to date at $57.37, about 62% below the 52-week high of $151. Here’s how Rocket Lab could hit $100 in 2027.

Wall Street Sees 62% Upside From Today’s Price

The average analyst target is $93.10, which implies 62% upside. Analysts carry 5 Strong Buy and 13 Buy ratings against 4 Holds and zero Sells. Consensus has revenue climbing from $980 million in 2026 to $1.34 billion in 2027, growth of roughly 37%.

Rocket Lab has also exceeded revenue estimates for four straight quarters. In Q3, revenue came in at $267.83 million[1] against a $257.18 million consensus, up 72.71% from a year earlier. GAAP EPS of -$0.12[1] missed the -$0.0665 estimate, but most of that gap came from one-time charges: a $27.26 million loss on debt repayment and $21.34 million in Iridium transaction costs.

Can Rocket Lab Really Hit $100? Let’s Do the Math

Rocket Lab isn’t profitable yet, so price-to-sales is the better metric. At a $36.26 billion market cap, the stock trades at about 27x 2027 revenue estimates. At $100, that multiple rises to roughly 47x. That’s a premium price, and the backlog helps support it. Backlog hit a record $3.57 billion[1], up 52% in one quarter.

Four catalysts could push Rocket Lab to $100:

  • Neutron pricing power: Neutron hasn’t flown yet, but its first 16 launches are booked[2] at a base price of $70 million. The next open slots are in the 2030s[2]. Management expects Neutron to become a 50%-plus[2] non-GAAP gross-margin business.
  • Defense spending: The FY2027 defense budget sets aside $59.7 billion for space-based systems. Rocket Lab already holds an $816 million SDA contract, the largest in its history.
  • Iridium: The deal is fully financed, and management says it would add strong cash flow as soon as it closes.
  • Higher launch prices: Beck expects “price increases across Electron and HASTE.”[2]

Rocket Lab’s History Says a 74% Gain Is Within Reach

A move to $100 would require a 74% gain. Rocket Lab has done more than that before: shares roughly quadrupled in 2024 and are up 252.4% over five years. With a beta of 3.176, the stock tends to move hard in both directions. The main risks are dilution (the company issued 36.8 million shares[2] through its at-the-market offering) and any further Neutron delays.

Is $100 Realistic? Here’s My Take

Reaching $100 would mean a 74% gain from here. Analysts already see 62% upside. Revenue keeps beating estimates, the backlog is at a record, and Neutron is sold out into the next decade. If Neutron flies smoothly in 2027 and the Iridium deal closes, $100 looks achievable. Gains of that magnitude are rare, which is why we studied what the biggest tech winners looked like early and put the pattern in a free playbook here. This is the plan for how Rocket Lab could post an outsized gain in 2027.

Contact [email protected] for any questions or corrections.

Alex Sirois

Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.
Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.
At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.

All articles →

Sources

  1. Rocket Lab Form 8-K (Q3 FY2026)U.S. Securities and Exchange Commission
  2. Rocket Lab Corporation Q3 2026 earnings callRocket Lab Corporation